1. Home
  2. WRLD vs KRRO Comparison

WRLD vs KRRO Comparison

Compare WRLD & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo World Acceptance Corporation

WRLD

World Acceptance Corporation

HOLD

Current Price

$184.90

Market Cap

895.3M

Sector

Finance

ML Signal

HOLD

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

N/A

Current Price

$13.89

Market Cap

187.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WRLD
KRRO
Founded
1962
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
895.3M
187.9M
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
WRLD
KRRO
Price
$184.90
$13.89
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$34.80
AVG Volume (30 Days)
45.2K
77.3K
Earning Date
04-30-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.33
N/A
Revenue
$585,166,700.00
$6,392,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.51
N/A
P/E Ratio
$143.42
N/A
Revenue Growth
3.60
181.46
52 Week Low
$110.00
$5.20
52 Week High
$227.68
$55.89

Technical Indicators

Market Signals
Indicator
WRLD
KRRO
Relative Strength Index (RSI) 53.14 59.06
Support Level $191.81 $9.76
Resistance Level $197.42 $14.42
Average True Range (ATR) 5.21 0.92
MACD 0.38 0.09
Stochastic Oscillator 71.55 67.01

Price Performance

Historical Comparison
WRLD
KRRO

About WRLD World Acceptance Corporation

World Acceptance Corp operates a small-loan consumer finance (installment loan) business. It offers short-term small installment loans, medium-term larger installment loans, related credit insurance and ancillary products and services to individuals. The Company generally serves individuals with limited access to other sources of consumer credit such as banks, credit unions, other consumer finance businesses and credit card lenders. The Company also offers income tax return preparation services to its loan customers and other individuals. The traditional installment loan industry is a fragmented segment of the consumer lending industry. The Company has one reportable segment: the consumer finance segment.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: